Comparison of risk stratification by OncotypeDX versus HOXB13/IL17BR index and molecular grade index in 166 estrogen receptor positive patients from multiple institutions

被引:0
|
作者
Sgroi, D.
Goss, P.
Steffel, L.
Lester, S.
Brock, J.
Hameed, O.
Hattab, E.
Ma, X-J
Erlander, M.
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Alabama, Birmingham, AL USA
[4] Indiana Univ, Indianapolis, IN 46204 USA
[5] AviaraDx, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:127S / 127S
页数:1
相关论文
共 21 条
  • [1] Comparison of risk stratification of ER-positive, node-negative breast cancer patients by Oncotype DX versus molecular grade index and HOXB13/IL17BR ratio
    Sgroi, D.
    Hameed, O.
    Hattab, E.
    Chang, B.
    Moulis, S.
    Steffel, L.
    Salunga, R.
    Ma, X.
    Erlander, M.
    Goss, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Prognostic Utility of HOXB13:IL17BR and Molecular Grade Index for Node-Negative Breast Cancer Patients
    Habel, L.
    Erlander, M.
    Achacoso, N.
    Ma, X-J
    Sgroi, D.
    Fehrenbacher, L.
    Greenberg, D.
    Quesenberry, C.
    CANCER RESEARCH, 2009, 69 (24) : 717S - 717S
  • [3] Validation of Prognostic Utility of HOXB13:IL17BR and Molecular Grade Index in Early Stage Breast Cancer
    Stal, O.
    Jerevall, P-L
    Ma, X-J
    Li, H.
    Salunga, R.
    Erlander, M.
    Sgroi, D.
    Holmlund, B.
    Skoog, L.
    Fornander, T.
    CANCER RESEARCH, 2009, 69 (24) : 504S - 504S
  • [4] Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
    P-L Jerevall
    X-J Ma
    H Li
    R Salunga
    N C Kesty
    M G Erlander
    D C Sgroi
    B Holmlund
    L Skoog
    T Fornander
    B Nordenskjöld
    O Stål
    British Journal of Cancer, 2011, 104 : 1762 - 1769
  • [5] HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease
    Habel, Laurel A.
    Sakoda, Lori C.
    Achacoso, Ninah
    Ma, Xiao-Jun
    Erlander, Mark G.
    Sgroi, Dennis C.
    Fehrenbacher, Louis
    Greenberg, Deborah
    Quesenberry, Charles P., Jr.
    BREAST CANCER RESEARCH, 2013, 15 (02)
  • [6] Prognostic utility of HOXB13: IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
    Jerevall, P-L
    Ma, X-J
    Li, H.
    Salunga, R.
    Kesty, N. C.
    Erlander, M. G.
    Sgroi, D. C.
    Holmlund, B.
    Skoog, L.
    Fornander, T.
    Nordenskjold, B.
    Stal, O.
    BRITISH JOURNAL OF CANCER, 2011, 104 (11) : 1762 - 1769
  • [7] HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease
    Laurel A Habel
    Lori C Sakoda
    Ninah Achacoso
    Xiao-Jun Ma
    Mark G Erlander
    Dennis C Sgroi
    Louis Fehrenbacher
    Deborah Greenberg
    Charles P Quesenberry
    Breast Cancer Research, 15
  • [8] Breast cancer index and assessment of tumor proliferation by molecular grade index (MGI) within distinct HOXB13/IL17BR (H/I) subsets
    Mahtani, Reshma
    Yuan, Yuan
    Wisinski, Kari B.
    Morris, Jay
    Salganik, Max
    Zhang, Yi
    Schnabel, Catherine A.
    Gadi, Vk
    CANCER RESEARCH, 2022, 82 (04)
  • [9] A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer
    Ma, Xiao-Jun
    Salunga, Ranelle
    Dahiya, Sonika
    Wang, Wilson
    Carney, Erin
    Durbecq, Virginie
    Harris, Adrian
    Goss, Paul
    Sotiriou, Christos
    Erlander, Mark
    Sgroi, Dennis
    CLINICAL CANCER RESEARCH, 2008, 14 (09) : 2601 - 2608
  • [10] Prediction of the clinical benefit of adjuvant tamoxifen therapy using Breast Cancer Index (HOXB13:IL17BR)
    Zhang, Yi
    Schroeder, Brock E.
    Jerevall, Piiha-Lotta
    Stal, Olle
    Sgroi, Dennis C.
    Erlander, Mark G.
    Schnabel, Catherine A.
    MOLECULAR CANCER RESEARCH, 2013, 11